Rilozarone

This classification denotes an antiarrhythmic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) E521I6380L. European Medicines Agency schedules Rilozarone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10318MIG. Rilozarone generally arises in the molecular formula C32H36BRCLN2O2. The term RILOZARONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 2, No. 3, 1988, list 28.) RILOZARONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule rilozarone under HS 29339990 and SITC 51577. As of Q4 2014, RILOZARONE remains US FDA's Preferred Term for this commodity. Rilozarone bears US NLM identifiers UMLS ID C2699088 and NCI Concept Code C75134. SMILES: BRC1C(C(N2C1CCCC2)C(=O)C1CC(CL)C(OCCCN(CCCC)CCCC)CC1)C1CCCCC1.